Diabetic patients with some types of cancer such as liver cancer have increased cancer-related mortality, suggesting that the diabetic condition promotes cancer progression.[35–39] Our finding of the AGEs-ROS-ChREBP pathway promoting liver cancer cell proliferation may provide a new explanation for increased liver cancer mortality in diabetic patients. This evidence concerns the gene MLXIPL and liver cancer.